Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,791 total articles

Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) Regains Full Nasdaq Compliance as Hearing is Cancelled; Company Advances Strategic Transformation and Global Technology Expansion
May 27, 2026
Hana Yamamoto
Press Releases

Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) Regains Full Nasdaq Compliance as Hearing is Cancelled; Company Advances Strategic Transformation and Global Technology Expansion

Trident Digital Tech Holdings Ltd., a Singapore-based technology holding company listed on Nasdaq, announced its regaining of full compliance with Nasdaq's minimum bid price rule, leading to the cancellation of a previously scheduled Nasdaq hearing. This resolution enables the company to maintain its Nasdaq listing, supporting its strategic transfo…

TDTH
Ingredion Achieves 96.3% Sustainable Sourcing of Tier 1 Priority Crops, Up From 25% Just Five Years Ago
May 27, 2026
Jordan Park
Press Releases

Ingredion Achieves 96.3% Sustainable Sourcing of Tier 1 Priority Crops, Up From 25% Just Five Years Ago

Ingredion Incorporated announced a significant milestone with over 96% of its tier 1 priority crops now sourced sustainably, up from 25% five years ago. This progress reflects the company's integrated approach to sustainability across its operations and partnerships. Additional highlights include high waste diversion rates, strengthened human right…

INGR
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
May 27, 2026
Jordan Park
Press Releases

New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia

Amarin Corporation presented new data at the EAS Congress 2026, demonstrating that risk-weighted apolipoprotein B (RW-apoB) more effectively identifies residual cardiovascular risk in statin-treated patients with elevated triglycerides than traditional lipid markers. This insight builds on the REDUCE-IT trial results, supporting the clinical releva…

AMRN
CDT Announces Canadian Patent for AZD5904 in Male Infertility
May 27, 2026
Hana Yamamoto
Press Releases

CDT Announces Canadian Patent for AZD5904 in Male Infertility

CDT Equity Inc. announced that the patent for AZD5904 in treating male infertility has been granted in Canada, completing patent approvals in all major pharmaceutical markets. This strengthens the company's intellectual property portfolio for AZD5904, a drug originally licensed from AstraZeneca, addressing a significant unmet need in the $4.4 billi…

CDT
Such App Beta Launch establishes House of Doge and the Dogecoin Foundation’s Scalable Direct-to-Consumer Platform
May 27, 2026
Jordan Park
Press Releases

Such App Beta Launch establishes House of Doge and the Dogecoin Foundation’s Scalable Direct-to-Consumer Platform

Brag House Holdings, in partnership with House of Doge and the Dogecoin Foundation, launched the beta version of Such, a direct-to-consumer mobile app integrating Dogecoin blockchain features to facilitate real-world commerce with DOGE. The app offers a multi-functional self-custodial wallet, a commerce engine for goods and service payments in Doge…

TBH
Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
May 27, 2026
Caleb Monroe
Press Releases

Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH

Madrigal Pharmaceuticals presented data from its Phase 3 MAESTRO program and real-world studies demonstrating that its drug Rezdiffra (resmetirom) significantly reduces cardiovascular risk markers and improves liver health in patients with metabolic dysfunction-associated steatohepatitis (MASH). The data show reductions in LDL-C, ApoB, Lp(a), and i…

MDGL
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026
Priya Menon
Press Releases

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

Enlivex Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, highlights the Rain Protocol's $100 million liquidity injection, placing Rain among the top three global prediction market platforms by total value locked. Enlivex holds substantial RAIN tokens and an option to acquire more, underpinning confidence in its dual strategy combining l…

ENLV
New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026
May 27, 2026
Marcus Reed
Press Releases

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

Altimmune, Inc. announced new analyses from its IMPACT Phase 2b trial showing pemvidutide, a novel glucagon/GLP-1 dual receptor agonist, significantly improves multiple non-invasive markers of metabolic dysfunction-associated steatohepatitis (MASH) activity and fibrosis after 24 weeks of treatment. AI-based digital pathology further confirmed antif…

ALT
4DMT to Participate in Upcoming Investor Conferences
May 27, 2026
Sofia Navarro
Press Releases

4DMT to Participate in Upcoming Investor Conferences

4D Molecular Therapeutics announced participation in upcoming June investor conferences, where company management will present and hold one-on-one meetings. The biotech firm is advancing late-stage gene therapy candidates targeting serious conditions such as wet age-related macular degeneration and cystic fibrosis, with multiple programs in clinica…

FDMT
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
May 27, 2026
Marcus Reed
Press Releases

Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis

Galectin Therapeutics presented new analyses from the NAVIGATE trial at the EASL 2026 Congress, showing that belapectin significantly reduces varices development and improves markers of fibrosis and portal hypertension risk in patients with advanced MASH cirrhosis. The data support belapectin's role as a disease-modifying therapy targeting fibrotic…

GALT
Live Oak Bank Grant Fuels Workforce Mobility Through The Forward Fund
May 27, 2026
Sofia Navarro
Press Releases

Live Oak Bank Grant Fuels Workforce Mobility Through The Forward Fund

Live Oak Bank has committed $1 million over five years to The Forward Fund, a North Carolina-based pay-it-forward financing program. The initiative provides zero-percent interest loans to working adults for career training in high-demand fields, fostering workforce upskilling and economic mobility. In its first year, the program issued $2.3 million…

LOB
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
May 27, 2026
Maya Rios
Press Releases

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

Mesa Laboratories, Inc. announced its fiscal year 2026 financial results, reporting 3.4% revenue growth driven primarily by its Sterilization and Disinfection Control division, offset by declines in Biopharmaceutical Development due to export controls and commercial execution challenges. Operating income rose 13.3%, aided by cost realignment and ba…

MLAB
Mid‑Market Companies Lose an Average of 25% of Their AI Budget Before Seeing a Single Return, New Freshworks Research Finds
May 27, 2026
Jordan Park
Press Releases

Mid‑Market Companies Lose an Average of 25% of Their AI Budget Before Seeing a Single Return, New Freshworks Research Finds

Freshworks Inc. releases a report detailing how mid-market companies lose on average 25% of their AI budgets to complexity overhead before achieving returns, with increased workload and integration challenges delaying ROI realization. Despite these hurdles, most mid-market organizations plan to increase AI investments, focusing on AI solutions that…

FRSH
Avalyn to Participate in the Jefferies Global Healthcare Conference
May 27, 2026
Hana Yamamoto
Press Releases

Avalyn to Participate in the Jefferies Global Healthcare Conference

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on inhaled therapies for serious respiratory diseases, announced that its management will present an overview of the company at the Jefferies Global Healthcare Conference. The presentation will cover Avalyn's development of inhaled formulations of antifibrotic drugs targeting pu…

AVLN
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
May 27, 2026
Derek Hwang
Press Releases

Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

Pacira BioSciences reports real-world study findings showing that use of EXPAREL, their non-opioid pain therapy, in outpatient total shoulder arthroplasty patients led to reduced opioid use, fewer opioid-related adverse events, and lower healthcare costs compared to standard analgesia. These findings support the expanding role of non-opioid pain ma…

PCRX
GrowGeneration to Participate in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026
May 27, 2026
Marcus Reed
Press Releases

GrowGeneration to Participate in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026

GrowGeneration Corp., a major supplier of specialty products for controlled environment agriculture and commercial cultivation, announced its management team's upcoming participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026. CEO Darren Lampert and CFO Gregory Sanders will engage in a Fireside Chat an…

GRWG
Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment
May 27, 2026
Priya Menon
Press Releases

Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment

Abacus Global Management has entered into a strategic alliance with Manning & Napier, including a minority equity investment of approximately $53 million. This partnership leverages Abacus's proprietary longevity data and actuarial expertise alongside Manning & Napier's wealth management platform, aiming to create enhanced lifespan-based financial …

ABX